MLEC Moolec Science S.A.: רווח למניה לשנה מתגלגלת

Moolec Science SA (MLEC) is implementing breakthrough technology for synthesizing porcine protein within soy crops. The company delegates agricultural production to independent farmers, focusing instead on laboratory research and development. However, GMO regulatory complexities and liquidity shortages create significant risks. The EPS ttm YoY growth rate demonstrates a sustainable trend, while the value -24.80 reflects the current magnitude of this indicator.

Moolec Science SA is transforming the food industry through molecular farming, replacing animal husbandry with the scalable cultivation of proteins in plants. The earnings per share trend over the last twelve months, reflected by the EPS (TTM) annual change, allows investors to filter out market noise and assess the real efficiency of this innovative model, considering the risk of potential compression of investment multiples.